BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 14975965)

  • 1. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis.
    Fennessy FM; Mortele KJ; Kluckert T; Gogate A; Ondategui-Parra S; Ros P; Silverman SG
    AJR Am J Roentgenol; 2004 Mar; 182(3):651-5. PubMed ID: 14975965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers.
    Haq A; Fraum TJ; Tao Y; Dehdashti F; LeBlanc M; Hoegger MJ; Luo J; Weilbaecher K; Peterson LL
    Breast Cancer (Auckl); 2023; 17():11782234231166476. PubMed ID: 37181949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic hepatic granuloma (suspected liver metastatic lesion on imaging) caused by liver retraction during laparoscopic gastrectomy: A case report.
    Bekki T; Yamamoto Y; Saeki Y; Arihiro K; Tanabe K; Ohdan H
    Clin Case Rep; 2020 Dec; 8(12):2353-2357. PubMed ID: 33363739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Note to: Does age affect liver function and the hepatic acute phase response after major abdominal surgery?
    Suttner SW; Sürder C; Lang K; Piper SN; Kumle B; Boldt J
    Intensive Care Med; 2023 Aug; 49(8):1045. PubMed ID: 37326649
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction and republication-TRICOTEL: defining symptomatic brain metastases in clinical trials.
    Dummer R; Tawbi H
    Lancet Oncol; 2023 Aug; 24(8):e327. PubMed ID: 37459871
    [No Abstract]   [Full Text] [Related]  

  • 6. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
    Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-associated liver morphological changes in hepatic metastases (CALMCHeM).
    Pope MC; Olson MC; Flicek KT; Patel NJ; Bolan CW; Menias CO; Wang Z; Venkatesh SK
    Diagn Interv Radiol; 2023 Jul; 29(4):571-578. PubMed ID: 37310196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
    Lother D; Robert M; Elwood E; Smith S; Tunariu N; Johnston SRD; Parton M; Bhaludin B; Millard T; Downey K; Sharma B
    Cancer Imaging; 2023 May; 23(1):53. PubMed ID: 37254225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis.
    Villani R; Di Cosimo F; Sangineto M; Romano AD; Serviddio G
    Sci Rep; 2022 Nov; 12(1):19865. PubMed ID: 36400809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis.
    Shreve LA; O'Leary C; Clark TWI; Stavropoulos SW; Soulen MC
    J Gastrointest Oncol; 2022 Feb; 13(1):279-287. PubMed ID: 35284108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.
    Calistri L; Rastrelli V; Nardi C; Maraghelli D; Vidali S; Pietragalla M; Colagrande S
    World J Gastroenterol; 2021 Dec; 27(46):7866-7893. PubMed ID: 35046618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
    Shinoda T; Tanahashi T; Sakuratani T; Ota M; Fujibayashi S; Kiriyama S; Matsumoto K; Yawata K; Sasaki Y; Osada S; Yamada M
    Mol Clin Oncol; 2022 Jan; 16(1):11. PubMed ID: 34881031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudocirrhosis in Breast Cancer - Experience From an Academic Cancer Center.
    Gopalakrishnan D; Shajihan A; Purysko AS; Abraham J
    Front Oncol; 2021; 11():679163. PubMed ID: 34277423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity.
    Engelman D; Moreau M; Lepida A; Zaouak Y; Paesmans M; Awada A
    ESMO Open; 2020 Jun; 5(3):e000695. PubMed ID: 32487541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent metastatic breast cancer presenting with portal hypertension and pseudocirrhosis.
    Adler M; Tang I; Gach MW; MacFaul G
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31767605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of pseudocirrhosis in metastatic breast cancer.
    Oliai C; Douek ML; Rhoane C; Bhutada A; Ge PS; Runyon BA; Wang X; Hurvitz SA
    Breast Cancer Res Treat; 2019 Sep; 177(2):409-417. PubMed ID: 31175499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudocirrhosis in a Patient with New-Onset Dysphagia and History of Ovarian Carcinoma.
    Zanazanian A; Kalani A; Tabibian JH
    ACG Case Rep J; 2018; 5():e29. PubMed ID: 29670925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudocirrhosis: A Case Series and Literature Review.
    Adike A; Karlin N; Menias C; Carey EJ
    Case Rep Gastroenterol; 2016; 10(2):381-391. PubMed ID: 27721722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of hepatic capsular retraction: a pictorial essay.
    Tan GX; Miranda R; Sutherland T
    Insights Imaging; 2016 Dec; 7(6):831-840. PubMed ID: 27686493
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.